APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Microbiology Testing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharmaceutical Microbiology Testing Market Outlook and Growth Opportunities 2026

4 June 2026216 pages

Choose your research edition.

Industry ResearchPharmaceutical Microbiology Testing Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Microbiology Testing Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Microbiology Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Microbiology Testing Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Microbiology Testing Market Analysis and Forecast 2026-2032223 pages · $4,950 USD

Market perspective

The global Pharmaceutical Microbiology Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharmaceutical Microbiology Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Microbiology Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Microbiology Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharmaceutical Microbiology Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharmaceutical Microbiology Testing market include Eurofins Scientific, Charles River Laboratories, SGS, WuXi AppTec, Nelson Labs, Pace Analytical, Thermo Fisher Scientific, Merck KGaA / MilliporeSigma and bioMérieux, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pharmaceutical Microbiology Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical Microbiology Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical Microbiology Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmaceutical Microbiology Testing market.

Pharmaceutical Microbiology Testing Segment by Company

Eurofins Scientific

Charles River Laboratories

SGS

WuXi AppTec

Nelson Labs

Pace Analytical

Thermo Fisher Scientific

Merck KGaA / MilliporeSigma

bioMérieux

Sartorius

STERIS

Intertek

ALS Limited

Microbac Laboratories

Alcami

Almac Group

Labcorp Drug Development

Element Materials Technology

Toxikon

Aurigene Pharmaceutical Services

Toray Research Center

Centre Testing International Group

Pony Testing International Group

Sumika Chemical Analysis Service

CMIC Group

LSI Medience

Pharmaceutical Microbiology Testing Segment by Type

Culture-Based Testing

Rapid Microbial Testing

Molecular Testing

Automated Microbiology Testing

Others

Pharmaceutical Microbiology Testing Segment by Application

Pharmaceutical Industry

CRO/CDMO

Medical Device

Others

Pharmaceutical Microbiology Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmaceutical Microbiology Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pharmaceutical Microbiology Testing key companies, revenue, market share, and recent developments.

3. To split the Pharmaceutical Microbiology Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pharmaceutical Microbiology Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmaceutical Microbiology Testing significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmaceutical Microbiology Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Microbiology Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Microbiology Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Microbiology Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Microbiology Testing industry.

Chapter 3: Detailed analysis of Pharmaceutical Microbiology Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pharmaceutical Microbiology Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pharmaceutical Microbiology Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical Microbiology Testing Industry Trends Table 2. Pharmaceutical Microbiology Testing Industry Drivers Table 3. Pharmaceutical Microbiology Testing Industry Opportunities and Challenges Table 4. Pharmaceutical Microbiology Testing Industry Restraints Table 5. Global Pharmaceutical Microbiology Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical Microbiology Testing Revenue Share by Company (2021-2026) Table 7. Global Pharmaceutical Microbiology Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pharmaceutical Microbiology Testing Key Company Manufacturing Base & Headquarters Table 9. Global Pharmaceutical Microbiology Testing Company, Product Type & Application Table 10. Global Pharmaceutical Microbiology Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pharmaceutical Microbiology Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Culture-Based Testing Table 15. Significant Companies of Rapid Microbial Testing Table 16. Significant Companies of Molecular Testing Table 17. Significant Companies of Automated Microbiology Testing Table 18. Significant Companies of Others Table 19. Global Pharmaceutical Microbiology Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Pharmaceutical Microbiology Testing Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Pharmaceutical Microbiology Testing Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Pharmaceutical Microbiology Testing Sales Value Share by Type (2021-2026) Table 23. Global Pharmaceutical Microbiology Testing Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Pharmaceutical Industry Table 25. Significant Companies of CRO/CDMO Table 26. Significant Companies of Medical Device Table 27. Significant Companies of Others Table 28. Global Pharmaceutical Microbiology Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Pharmaceutical Microbiology Testing Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Pharmaceutical Microbiology Testing Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Pharmaceutical Microbiology Testing Sales Value Share by Application (2021-2026) Table 32. Global Pharmaceutical Microbiology Testing Sales Value Share by Application (2027-2032) Table 33. Global Pharmaceutical Microbiology Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Pharmaceutical Microbiology Testing Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Pharmaceutical Microbiology Testing Sales Value Share by Region (2021-2026) Table 36. Global Pharmaceutical Microbiology Testing Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Pharmaceutical Microbiology Testing Sales Value Share by Region (2027-2032) Table 38. Global Pharmaceutical Microbiology Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Pharmaceutical Microbiology Testing Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Pharmaceutical Microbiology Testing Sales Value Market Share by Country (2021-2026) Table 41. Global Pharmaceutical Microbiology Testing Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Pharmaceutical Microbiology Testing Sales Value Market Share by Country (2027-2032) Table 43. Eurofins Scientific Company Information Table 44. Eurofins Scientific Business Overview Table 45. Eurofins Scientific Pharmaceutical Microbiology Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Eurofins Scientific Pharmaceutical Microbiology Testing Product Portfolio Table 47. Eurofins Scientific Recent Development Table 48. Charles River Laboratories Company Information Table 49. Charles River Laboratories Business Overview Table 50. Charles River Laboratories Pharmaceutical Microbiology Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Charles River Laboratories Pharmaceutical Microbiology Testing Product Portfolio Table 52. Charles River Laboratories Recent Development Table 53. SGS Company Information Table 54. SGS Business Overview Table 55. SGS Pharmaceutical Microbiology Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. SGS Pharmaceutical Microbiology Testing Product Portfolio Table 57. SGS Recent Development Table 58. WuXi AppTec Company Information Table 59. WuXi AppTec Business Overview Table 60. WuXi AppTec Pharmaceutical Microbiology Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. WuXi AppTec Pharmaceutical Microbiology Testing Product Portfolio Table 62. WuXi AppTec Recent Development Table 63. Nelson Labs Company Information Table 64. Nelson Labs Business Overview Table 65. Nelson Labs Pharmaceutical Microbiology Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Nelson Labs Pharmaceutical Microbiology Testing Product Portfolio Table 67. Nelson Labs Recent Development Table 68. Pace Analytical Company Information Table 69. Pace Analytical Business Overview Table 70. Pace Analytical Pharmaceutical Microbiology Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Pace Analytical Pharmaceutical Microbiology Testing Product Portfolio Table 72. Pace Analytical Recent Development Table 73. Thermo Fisher Scientific Company Information Table 74. Thermo Fisher Scientific Business Overview Table 75. Thermo Fisher Scientific Pharmaceutical Microbiology Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Thermo Fisher Scientific Pharmaceutical Microbiology Testing Product Portfolio Table 77. Thermo Fisher Scientific Recent Development Table 78. Merck KGaA / MilliporeSigma Company Information Table 79. Merck KGaA / MilliporeSigma Business Overview Table 80. Merck KGaA / MilliporeSigma Pharmaceutical Microbiology Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Merck KGaA / MilliporeSigma Pharmaceutical Microbiology Testing Product Portfolio Table 82. Merck KGaA / MilliporeSigma Recent Development Table 83. bioMérieux Company Information Table 84. bioMérieux Business Overview Table 85. bioMérieux Pharmaceutical Microbiology Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. bioMérieux Pharmaceutical Microbiology Testing Product Portfolio Table 87. bioMérieux Recent Development Table 88. Sartorius Company Information Table 89. Sartorius Business Overview Table 90. Sartorius Pharmaceutical Microbiology Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Sartorius Pharmaceutical Microbiology Testing Product Portfolio Table 92. Sartorius Recent Development Table 93. STERIS Company Information Table 94. STERIS Business Overview Table 95. STERIS Pharmaceutical Microbiology Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. STERIS Pharmaceutical Microbiology Testing Product Portfolio Table 97. STERIS Recent Development Table 98. Intertek Company Information Table 99. Intertek Business Overview Table 100. Intertek Pharmaceutical Microbiology Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Intertek Pharmaceutical Microbiology Testing Product Portfolio Table 102. Intertek Recent Development Table 103. ALS Limited Company Information Table 104. ALS Limited Business Overview Table 105. ALS Limited Pharmaceutical Microbiology Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. ALS Limited Pharmaceutical Microbiology Testing Product Portfolio Table 107. ALS Limited Recent Development Table 108. Microbac Laboratories Company Information Table 109. Microbac Laboratories Business Overview Table 110. Microbac Laboratories Pharmaceutical Microbiology Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Microbac Laboratories Pharmaceutical Microbiology Testing Product Portfolio Table 112. Microbac Laboratories Recent Development Table 113. Alcami Company Information Table 114. Alcami Business Overview Table 115. Alcami Pharmaceutical Microbiology Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Alcami Pharmaceutical Microbiology Testing Product Portfolio Table 117. Alcami Recent Development Table 118. Almac Group Company Information Table 119. Almac Group Business Overview Table 120. Almac Group Pharmaceutical Microbiology Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Almac Group Pharmaceutical Microbiology Testing Product Portfolio Table 122. Almac Group Recent Development Table 123. Labcorp Drug Development Company Information Table 124. Labcorp Drug Development Business Overview Table 125. Labcorp Drug Development Pharmaceutical Microbiology Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Labcorp Drug Development Pharmaceutical Microbiology Testing Product Portfolio Table 127. Labcorp Drug Development Recent Development Table 128. Element Materials Technology Company Information Table 129. Element Materials Technology Business Overview Table 130. Element Materials Technology Pharmaceutical Microbiology Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Element Materials Technology Pharmaceutical Microbiology Testing Product Portfolio Table 132. Element Materials Technology Recent Development Table 133. Toxikon Company Information Table 134. Toxikon Business Overview Table 135. Toxikon Pharmaceutical Microbiology Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. Toxikon Pharmaceutical Microbiology Testing Product Portfolio Table 137. Toxikon Recent Development Table 138. Aurigene Pharmaceutical Services Company Information Table 139. Aurigene Pharmaceutical Services Business Overview Table 140. Aurigene Pharmaceutical Services Pharmaceutical Microbiology Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 141. Aurigene Pharmaceutical Services Pharmaceutical Microbiology Testing Product Portfolio Table 142. Aurigene Pharmaceutical Services Recent Development Table 143. Toray Research Center Company Information Table 144. Toray Research Center Business Overview Table 145. Toray Research Center Pharmaceutical Microbiology Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 146. Toray Research Center Pharmaceutical Microbiology Testing Product Portfolio Table 147. Toray Research Center Recent Development Table 148. Centre Testing International Group Company Information Table 149. Centre Testing International Group Business Overview Table 150. Centre Testing International Group Pharmaceutical Microbiology Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 151. Centre Testing International Group Pharmaceutical Microbiology Testing Product Portfolio Table 152. Centre Testing International Group Recent Development Table 153. Pony Testing International Group Company Information Table 154. Pony Testing International Group Business Overview Table 155. Pony Testing International Group Pharmaceutical Microbiology Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 156. Pony Testing International Group Pharmaceutical Microbiology Testing Product Portfolio Table 157. Pony Testing International Group Recent Development Table 158. Sumika Chemical Analysis Service Company Information Table 159. Sumika Chemical Analysis Service Business Overview Table 160. Sumika Chemical Analysis Service Pharmaceutical Microbiology Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 161. Sumika Chemical Analysis Service Pharmaceutical Microbiology Testing Product Portfolio Table 162. Sumika Chemical Analysis Service Recent Development Table 163. CMIC Group Company Information Table 164. CMIC Group Business Overview Table 165. CMIC Group Pharmaceutical Microbiology Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 166. CMIC Group Pharmaceutical Microbiology Testing Product Portfolio Table 167. CMIC Group Recent Development Table 168. LSI Medience Company Information Table 169. LSI Medience Business Overview Table 170. LSI Medience Pharmaceutical Microbiology Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 171. LSI Medience Pharmaceutical Microbiology Testing Product Portfolio Table 172. LSI Medience Recent Development Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Pharmaceutical Microbiology Testing Product Image Figure 2. Global Pharmaceutical Microbiology Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Microbiology Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical Microbiology Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Culture-Based Testing Image Figure 8. Rapid Microbial Testing Image Figure 9. Molecular Testing Image Figure 10. Automated Microbiology Testing Image Figure 11. Others Image Figure 12. Global Pharmaceutical Microbiology Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Pharmaceutical Microbiology Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Pharmaceutical Microbiology Testing Sales Value Share by Type (2021-2032) Figure 15. Pharmaceutical Industry Image Figure 16. CRO/CDMO Image Figure 17. Medical Device Image Figure 18. Others Image Figure 19. Global Pharmaceutical Microbiology Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Pharmaceutical Microbiology Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Pharmaceutical Microbiology Testing Sales Value Share by Application (2021-2032) Figure 22. Global Pharmaceutical Microbiology Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Pharmaceutical Microbiology Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Pharmaceutical Microbiology Testing Sales Value (2021-2032) & (US$ Million) Figure 25. North America Pharmaceutical Microbiology Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Pharmaceutical Microbiology Testing Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Pharmaceutical Microbiology Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Pharmaceutical Microbiology Testing Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Pharmaceutical Microbiology Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Pharmaceutical Microbiology Testing Sales Value (2021-2032) & (US$ Million) Figure 31. South America Pharmaceutical Microbiology Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Pharmaceutical Microbiology Testing Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Pharmaceutical Microbiology Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Culture-Based Testing
  • Rapid Microbial Testing
  • Molecular Testing
  • Automated Microbiology Testing
  • Others
Applications
  • Pharmaceutical Industry
  • CRO/CDMO
  • Medical Device
  • Others
Companies covered
  • Eurofins Scientific
  • Charles River Laboratories
  • SGS
  • WuXi AppTec
  • Nelson Labs
  • Pace Analytical
  • Thermo Fisher Scientific
  • Merck KGaA / MilliporeSigma
  • bioMérieux
  • Sartorius
  • STERIS
  • Intertek
  • ALS Limited
  • Microbac Laboratories
  • Alcami
  • Almac Group
  • Labcorp Drug Development
  • Element Materials Technology
  • Toxikon
  • Aurigene Pharmaceutical Services
  • Toray Research Center
  • Centre Testing International Group
  • Pony Testing International Group
  • Sumika Chemical Analysis Service
  • CMIC Group
  • LSI Medience

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmaceutical Microbiology Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmaceutical Microbiology Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pharmaceutical Microbiology Testing Market Dynamics
  1. 2.1 Pharmaceutical Microbiology Testing Industry Trends
  2. 2.2 Pharmaceutical Microbiology Testing Industry Drivers
  3. 2.3 Pharmaceutical Microbiology Testing Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Microbiology Testing Industry Restraints
3 Pharmaceutical Microbiology Testing Market by Company
  1. 3.1 Global Pharmaceutical Microbiology Testing Company Revenue Ranking in 2025
  2. 3.2 Global Pharmaceutical Microbiology Testing Revenue by Company (2021-2026)
  3. 3.3 Global Pharmaceutical Microbiology Testing Company Ranking (2024-2026)
  4. 3.4 Global Pharmaceutical Microbiology Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global Pharmaceutical Microbiology Testing Company Product Type and Application
  6. 3.6 Global Pharmaceutical Microbiology Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pharmaceutical Microbiology Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pharmaceutical Microbiology Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pharmaceutical Microbiology Testing Market by Type
  1. 4.1 Pharmaceutical Microbiology Testing Type Introduction
  2. 4.1.1 Culture-Based Testing
  3. 4.1.2 Rapid Microbial Testing
  4. 4.1.3 Molecular Testing
  5. 4.1.4 Automated Microbiology Testing
  6. 4.1.5 Others
  7. 4.2 Global Pharmaceutical Microbiology Testing Sales Value by Type
  8. 4.2.1 Global Pharmaceutical Microbiology Testing Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Pharmaceutical Microbiology Testing Sales Value by Type (2021-2032)
  10. 4.2.3 Global Pharmaceutical Microbiology Testing Sales Value Share by Type (2021-2032)
5 Pharmaceutical Microbiology Testing Market by Application
  1. 5.1 Pharmaceutical Microbiology Testing Application Introduction
  2. 5.1.1 Pharmaceutical Industry
  3. 5.1.2 CRO/CDMO
  4. 5.1.3 Medical Device
  5. 5.1.4 Others
  6. 5.2 Global Pharmaceutical Microbiology Testing Sales Value by Application
  7. 5.2.1 Global Pharmaceutical Microbiology Testing Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Pharmaceutical Microbiology Testing Sales Value by Application (2021-2032)
  9. 5.2.3 Global Pharmaceutical Microbiology Testing Sales Value Share by Application (2021-2032)
6 Pharmaceutical Microbiology Testing Regional Value Analysis
  1. 6.1 Global Pharmaceutical Microbiology Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical Microbiology Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical Microbiology Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pharmaceutical Microbiology Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmaceutical Microbiology Testing Sales Value (2021-2032)
  7. 6.3.2 North America Pharmaceutical Microbiology Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pharmaceutical Microbiology Testing Sales Value (2021-2032)
  10. 6.4.2 Europe Pharmaceutical Microbiology Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pharmaceutical Microbiology Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pharmaceutical Microbiology Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pharmaceutical Microbiology Testing Sales Value (2021-2032)
  16. 6.6.2 South America Pharmaceutical Microbiology Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pharmaceutical Microbiology Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pharmaceutical Microbiology Testing Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical Microbiology Testing Country-level Value Analysis
  1. 7.1 Global Pharmaceutical Microbiology Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmaceutical Microbiology Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pharmaceutical Microbiology Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pharmaceutical Microbiology Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pharmaceutical Microbiology Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pharmaceutical Microbiology Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pharmaceutical Microbiology Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eurofins Scientific
  2. 8.1.1 Eurofins Scientific Company Information
  3. 8.1.2 Eurofins Scientific Business Overview
  4. 8.1.3 Eurofins Scientific Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eurofins Scientific Pharmaceutical Microbiology Testing Product Portfolio
  6. 8.1.5 Eurofins Scientific Recent Developments
  7. 8.2 Charles River Laboratories
  8. 8.2.1 Charles River Laboratories Company Information
  9. 8.2.2 Charles River Laboratories Business Overview
  10. 8.2.3 Charles River Laboratories Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Charles River Laboratories Pharmaceutical Microbiology Testing Product Portfolio
  12. 8.2.5 Charles River Laboratories Recent Developments
  13. 8.3 SGS
  14. 8.3.1 SGS Company Information
  15. 8.3.2 SGS Business Overview
  16. 8.3.3 SGS Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 SGS Pharmaceutical Microbiology Testing Product Portfolio
  18. 8.3.5 SGS Recent Developments
  19. 8.4 WuXi AppTec
  20. 8.4.1 WuXi AppTec Company Information
  21. 8.4.2 WuXi AppTec Business Overview
  22. 8.4.3 WuXi AppTec Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 WuXi AppTec Pharmaceutical Microbiology Testing Product Portfolio
  24. 8.4.5 WuXi AppTec Recent Developments
  25. 8.5 Nelson Labs
  26. 8.5.1 Nelson Labs Company Information
  27. 8.5.2 Nelson Labs Business Overview
  28. 8.5.3 Nelson Labs Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Nelson Labs Pharmaceutical Microbiology Testing Product Portfolio
  30. 8.5.5 Nelson Labs Recent Developments
  31. 8.6 Pace Analytical
  32. 8.6.1 Pace Analytical Company Information
  33. 8.6.2 Pace Analytical Business Overview
  34. 8.6.3 Pace Analytical Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pace Analytical Pharmaceutical Microbiology Testing Product Portfolio
  36. 8.6.5 Pace Analytical Recent Developments
  37. 8.7 Thermo Fisher Scientific
  38. 8.7.1 Thermo Fisher Scientific Company Information
  39. 8.7.2 Thermo Fisher Scientific Business Overview
  40. 8.7.3 Thermo Fisher Scientific Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Thermo Fisher Scientific Pharmaceutical Microbiology Testing Product Portfolio
  42. 8.7.5 Thermo Fisher Scientific Recent Developments
  43. 8.8 Merck KGaA / MilliporeSigma
  44. 8.8.1 Merck KGaA / MilliporeSigma Company Information
  45. 8.8.2 Merck KGaA / MilliporeSigma Business Overview
  46. 8.8.3 Merck KGaA / MilliporeSigma Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Merck KGaA / MilliporeSigma Pharmaceutical Microbiology Testing Product Portfolio
  48. 8.8.5 Merck KGaA / MilliporeSigma Recent Developments
  49. 8.9 bioMérieux
  50. 8.9.1 bioMérieux Company Information
  51. 8.9.2 bioMérieux Business Overview
  52. 8.9.3 bioMérieux Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 bioMérieux Pharmaceutical Microbiology Testing Product Portfolio
  54. 8.9.5 bioMérieux Recent Developments
  55. 8.10 Sartorius
  56. 8.10.1 Sartorius Company Information
  57. 8.10.2 Sartorius Business Overview
  58. 8.10.3 Sartorius Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sartorius Pharmaceutical Microbiology Testing Product Portfolio
  60. 8.10.5 Sartorius Recent Developments
  61. 8.11 STERIS
  62. 8.11.1 STERIS Company Information
  63. 8.11.2 STERIS Business Overview
  64. 8.11.3 STERIS Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 STERIS Pharmaceutical Microbiology Testing Product Portfolio
  66. 8.11.5 STERIS Recent Developments
  67. 8.12 Intertek
  68. 8.12.1 Intertek Company Information
  69. 8.12.2 Intertek Business Overview
  70. 8.12.3 Intertek Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Intertek Pharmaceutical Microbiology Testing Product Portfolio
  72. 8.12.5 Intertek Recent Developments
  73. 8.13 ALS Limited
  74. 8.13.1 ALS Limited Company Information
  75. 8.13.2 ALS Limited Business Overview
  76. 8.13.3 ALS Limited Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  77. 8.13.4 ALS Limited Pharmaceutical Microbiology Testing Product Portfolio
  78. 8.13.5 ALS Limited Recent Developments
  79. 8.14 Microbac Laboratories
  80. 8.14.1 Microbac Laboratories Company Information
  81. 8.14.2 Microbac Laboratories Business Overview
  82. 8.14.3 Microbac Laboratories Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Microbac Laboratories Pharmaceutical Microbiology Testing Product Portfolio
  84. 8.14.5 Microbac Laboratories Recent Developments
  85. 8.15 Alcami
  86. 8.15.1 Alcami Company Information
  87. 8.15.2 Alcami Business Overview
  88. 8.15.3 Alcami Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Alcami Pharmaceutical Microbiology Testing Product Portfolio
  90. 8.15.5 Alcami Recent Developments
  91. 8.16 Almac Group
  92. 8.16.1 Almac Group Company Information
  93. 8.16.2 Almac Group Business Overview
  94. 8.16.3 Almac Group Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Almac Group Pharmaceutical Microbiology Testing Product Portfolio
  96. 8.16.5 Almac Group Recent Developments
  97. 8.17 Labcorp Drug Development
  98. 8.17.1 Labcorp Drug Development Company Information
  99. 8.17.2 Labcorp Drug Development Business Overview
  100. 8.17.3 Labcorp Drug Development Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Labcorp Drug Development Pharmaceutical Microbiology Testing Product Portfolio
  102. 8.17.5 Labcorp Drug Development Recent Developments
  103. 8.18 Element Materials Technology
  104. 8.18.1 Element Materials Technology Company Information
  105. 8.18.2 Element Materials Technology Business Overview
  106. 8.18.3 Element Materials Technology Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Element Materials Technology Pharmaceutical Microbiology Testing Product Portfolio
  108. 8.18.5 Element Materials Technology Recent Developments
  109. 8.19 Toxikon
  110. 8.19.1 Toxikon Company Information
  111. 8.19.2 Toxikon Business Overview
  112. 8.19.3 Toxikon Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Toxikon Pharmaceutical Microbiology Testing Product Portfolio
  114. 8.19.5 Toxikon Recent Developments
  115. 8.20 Aurigene Pharmaceutical Services
  116. 8.20.1 Aurigene Pharmaceutical Services Company Information
  117. 8.20.2 Aurigene Pharmaceutical Services Business Overview
  118. 8.20.3 Aurigene Pharmaceutical Services Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Aurigene Pharmaceutical Services Pharmaceutical Microbiology Testing Product Portfolio
  120. 8.20.5 Aurigene Pharmaceutical Services Recent Developments
  121. 8.21 Toray Research Center
  122. 8.21.1 Toray Research Center Company Information
  123. 8.21.2 Toray Research Center Business Overview
  124. 8.21.3 Toray Research Center Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Toray Research Center Pharmaceutical Microbiology Testing Product Portfolio
  126. 8.21.5 Toray Research Center Recent Developments
  127. 8.22 Centre Testing International Group
  128. 8.22.1 Centre Testing International Group Company Information
  129. 8.22.2 Centre Testing International Group Business Overview
  130. 8.22.3 Centre Testing International Group Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Centre Testing International Group Pharmaceutical Microbiology Testing Product Portfolio
  132. 8.22.5 Centre Testing International Group Recent Developments
  133. 8.23 Pony Testing International Group
  134. 8.23.1 Pony Testing International Group Company Information
  135. 8.23.2 Pony Testing International Group Business Overview
  136. 8.23.3 Pony Testing International Group Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Pony Testing International Group Pharmaceutical Microbiology Testing Product Portfolio
  138. 8.23.5 Pony Testing International Group Recent Developments
  139. 8.24 Sumika Chemical Analysis Service
  140. 8.24.1 Sumika Chemical Analysis Service Company Information
  141. 8.24.2 Sumika Chemical Analysis Service Business Overview
  142. 8.24.3 Sumika Chemical Analysis Service Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Sumika Chemical Analysis Service Pharmaceutical Microbiology Testing Product Portfolio
  144. 8.24.5 Sumika Chemical Analysis Service Recent Developments
  145. 8.25 CMIC Group
  146. 8.25.1 CMIC Group Company Information
  147. 8.25.2 CMIC Group Business Overview
  148. 8.25.3 CMIC Group Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  149. 8.25.4 CMIC Group Pharmaceutical Microbiology Testing Product Portfolio
  150. 8.25.5 CMIC Group Recent Developments
  151. 8.26 LSI Medience
  152. 8.26.1 LSI Medience Company Information
  153. 8.26.2 LSI Medience Business Overview
  154. 8.26.3 LSI Medience Pharmaceutical Microbiology Testing Revenue and Gross Margin (2021-2026)
  155. 8.26.4 LSI Medience Pharmaceutical Microbiology Testing Product Portfolio
  156. 8.26.5 LSI Medience Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst